Literature DB >> 1964121

Epstein-Barr virus infection rapidly progressing to monoclonal lymphoproliferative disease in a child with selective immunodeficiency.

V Schuster1, H W Kreth, H K Müller-Hermelink, H I Huppertz, A C Feller, D Neumann-Haefelin, H Wiegand, N Müller-Lantzsch.   

Abstract

We report on a 30-month-old previously healthy Turkish boy who presented with fever, hepatosplenomegaly and generalized lymphadenopathy. He died 4 months after admission in spite of treatment with steroids, acycloguanosine and cyclophosphamide. Epstein-Barr virus (EBV) DNA was detected in the patient's bone marrow and in a lymph node biopsy. Cells from the lymph node biopsy showed monoclonal rearrangements of immunoglobulin heavy chain genes but no rearrangements of T-cell receptor beta-chain genes or immunoglobulin kappa chain genes. Serological data indicated chronic active EBV infection. There was a slight increase of CD8 positive cells in peripheral blood and a normal response to T-cell mitogens. However, T-cell lines established with interleukin 2 from lymph node biopsy completely failed to kill autologous EBV-transformed B-cells and K 562 target cells. Moreover, in regression tests the patient's peripheral blood mononuclear cells completely failed to limit outgrowth of autologous EBV infected B-cells. We conclude that the patient's selective immuno-deficiency had led to the rapid development of EBV-associated monoclonal lymphoproliferation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1964121     DOI: 10.1007/bf01959480

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  36 in total

1.  Immunoglobulin and T cell receptor gene rearrangements in human lymphoma and leukemia.

Authors:  M E Williams; D J Innes; M J Borowitz; M A Lovell; S H Swerdlow; P E Hurtubise; R K Brynes; W C Chan; G E Byrne; C C Whitcomb
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

Review 3.  Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation.

Authors:  D W Hanto; G Frizzera; K J Gajl-Peczalska; R L Simmons
Journal:  Transplantation       Date:  1985-05       Impact factor: 4.939

4.  Diagnostic significance of antibodies to the Epstein-Barr virus-specific membrane antigen gp250.

Authors:  W Jilg; H Wolf
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

5.  Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes.

Authors:  D J Moss; A B Rickinson; J H Pope
Journal:  Int J Cancer       Date:  1978-12       Impact factor: 7.396

6.  Clonal analysis of HLA-restricted virus-specific cytotoxic T lymphocytes from cerebrospinal fluid in mumps meningitis.

Authors:  B Fleischer; H W Kreth
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

7.  Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments.

Authors:  P A Hieter; E E Max; J G Seidman; J V Maizel; P Leder
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

8.  Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders.

Authors:  D L Birx; R R Redfield; G Tosato
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

9.  Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects.

Authors:  S Harada; K Sakamoto; J K Seeley; T Lindsten; T Bechtold; J Yetz; G Rogers; G Pearson; D T Purtilo
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

10.  Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection.

Authors:  M Ho; G Miller; R W Atchison; M K Breinig; J S Dummer; W Andiman; T E Starzl; R Eastman; B P Griffith; R L Hardesty
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

View more
  3 in total

1.  Fatal Lymphoproliferative Disease in Two Siblings Lacking Functional FAAP24.

Authors:  Svenja Daschkey; Kirsten Bienemann; Volker Schuster; Hans Wolfgang Kreth; René Martin Linka; Andrea Hönscheid; Gerhard Fritz; Christian Johannes; Bernhard Fleckenstein; Bettina Kempkes; Michael Gombert; Sebastian Ginzel; Arndt Borkhardt
Journal:  J Clin Immunol       Date:  2016-07-29       Impact factor: 8.317

Review 2.  Epstein-Barr virus infection and associated diseases in children. I. Pathogenesis, epidemiology and clinical aspects.

Authors:  V Schuster; H W Kreth
Journal:  Eur J Pediatr       Date:  1992-10       Impact factor: 3.183

3.  Intact antigen presentation for Epstein-Barr virus (EBV)-specific CTL by a lymphoblastoid cell line established from a patient with severe chronic active EBV infection.

Authors:  H Kimura; I Tsuge; S Imai; M Yamamoto; K Kuzushima; T Osato; T Morishima
Journal:  Med Microbiol Immunol       Date:  1995-08       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.